228 related articles for article (PubMed ID: 29783500)
1. Beyond TPMT: genetic influences on thiopurine drug responses in inflammatory bowel disease.
Roberts RL; Gearry RB; Kennedy MA; Barclay ML
Per Med; 2008 May; 5(3):233-248. PubMed ID: 29783500
[TBL] [Abstract][Full Text] [Related]
2. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
[TBL] [Abstract][Full Text] [Related]
3. IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.
Haglund S; Taipalensuu J; Peterson C; Almer S
Br J Clin Pharmacol; 2008 Jan; 65(1):69-77. PubMed ID: 17662091
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
5. Typing TPMT and ITPase to detect azathioprine toxicity.
Arenas M; Marinaki A; Ansari A; Sanderson J
Per Med; 2006 Feb; 3(1):45-59. PubMed ID: 29783434
[TBL] [Abstract][Full Text] [Related]
6. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
Teml A; Schaeffeler E; Herrlinger KR; Klotz U; Schwab M
Clin Pharmacokinet; 2007; 46(3):187-208. PubMed ID: 17328579
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
[TBL] [Abstract][Full Text] [Related]
8. Red Blood cell IMPDH activity in adults and children with or without azathioprine: Relationship between thiopurine metabolites, ITPA and TPMT activities.
Citterio-Quentin A; El Mahmoudi A; Perret T; Conway A; Ryan A; Beringer A; Lachaux A; Boulieu R
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):600-606. PubMed ID: 30451390
[TBL] [Abstract][Full Text] [Related]
9. A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs.
Skrzypczak-Zielinska M; Borun P; Bartkowiak-Kaczmarek A; Zakerska-Banaszak O; Walczak M; Dobrowolska A; Kurzawski M; Waszak M; Lipinski D; Plawski A; Slomski R
Mol Diagn Ther; 2016 Oct; 20(5):493-9. PubMed ID: 27307154
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.
Hindorf U; Lindqvist M; Peterson C; Söderkvist P; Ström M; Hjortswang H; Pousette A; Almer S
Gut; 2006 Oct; 55(10):1423-31. PubMed ID: 16543290
[TBL] [Abstract][Full Text] [Related]
11. Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.
Asadov C; Aliyeva G; Mustafayeva K
Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):23-30. PubMed ID: 28552060
[TBL] [Abstract][Full Text] [Related]
12. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
[TBL] [Abstract][Full Text] [Related]
13. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
[TBL] [Abstract][Full Text] [Related]
14. Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease.
Ding L; Zhang FB; Liu H; Gao X; Bi HC; Wang XD; Chen BL; Zhang Y; Zhao LZ; Zhong GP; Hu PJ; Chen MH; Huang M
Inflamm Bowel Dis; 2012 Jan; 18(1):63-73. PubMed ID: 21381155
[TBL] [Abstract][Full Text] [Related]
15. Deletion of glutathione-s-transferase m1 reduces azathioprine metabolite concentrations in young patients with inflammatory bowel disease.
Stocco G; Cuzzoni E; De Iudicibus S; Franca R; Favretto D; Malusà N; Londero M; Cont G; Bartoli F; Martelossi S; Ventura A; Decorti G
J Clin Gastroenterol; 2014 Jan; 48(1):43-51. PubMed ID: 23787247
[TBL] [Abstract][Full Text] [Related]
16. Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of experts.
Roblin X; Oussalah A; Chevaux JB; Sparrow M; Peyrin-Biroulet L
Inflamm Bowel Dis; 2011 Dec; 17(12):2480-7. PubMed ID: 21351210
[TBL] [Abstract][Full Text] [Related]
17. A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.
Zabala-Fernández W; Barreiro-de Acosta M; Echarri A; Carpio D; Lorenzo A; Castro J; Martínez-Ares D; Pereira S; Martin-Granizo I; Corton M; Carracedo A; Barros F
J Gastrointestin Liver Dis; 2011 Sep; 20(3):247-53. PubMed ID: 21961091
[TBL] [Abstract][Full Text] [Related]
18. High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment.
van Egmond R; Chin P; Zhang M; Sies CW; Barclay ML
Aliment Pharmacol Ther; 2012 May; 35(10):1181-9. PubMed ID: 22486532
[TBL] [Abstract][Full Text] [Related]
19. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
[TBL] [Abstract][Full Text] [Related]
20. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
